Wataƙila babu wani abu da ya fi ɓata rai kamar ganin tsohuwar mahaifiyarmu, mahaifinmu, kakarmu, ko kawunmu suna mantawa da komai a hankali. Tun daga manta ƙananan abubuwa zuwa rashin tuna ko su waye 'ya'yanmu, cutar Alzheimer yanayi ne da ke sa mu duka marasa taimako a matsayinmu na iyali. To, me zai faru idan ɗan hasken rana ya bayyana a tsakiyar irin wannan gajimare mai duhu? Me zai faru idan akwai labari game da wani sabon magani wanda zai iya rage ci gaban cutar Alzheimer? A yau za mu yi magana game da wani sabon bincike da ya kawo irin wannan bege.
Menene Donanemab? Ta yaya yake aiki?
A taƙaice dai, Donanemab wani sabon magani ne da ake ƙirƙirowa don magance cutar Alzheimer. Kamfanin magunguna Eli Lilly ne ke ƙera shi.
Yanzu, ana kyautata zaton babban abin da ke haifar da cutar Alzheimer shine tarin wani sinadari mai cutarwa da ake kira amyloid plaques a cikin kwakwalwa. Kamar tsatsa da ke fitowa a cikin bututun ruwa, waɗannan sinadari suna taruwa tsakanin ƙwayoyin jijiyoyi a cikin kwakwalwa kuma suna tsoma baki a cikin ayyukansu. Bayan lokaci, wannan shine abin da ke haifar da alamu kamar rashin tunawa da hankali da wahalar tunani.
Maganin Donanemab musamman yana kai hari ga waɗannan tarin da ake kira amyloid plaques. Idan aka ba wa jiki wannan magani, yana zuwa kwakwalwa, yana gane waɗannan tarin furotin da ba a so, sannan ya fara cire su. Wannan yana aiki kamar maganin rigakafi . Tushen kimiyya a bayan wannan shine cewa ta hanyar tsaftace kwakwalwa ta wannan hanyar, yana iya rage ci gaban cutar.
Sakamakon wannan bincike ya yi nasara sosai har Eli Lilly tana shirin neman izinin Hukumar Abinci da Magunguna ta Amurka (FDA) don amincewa da wannan maganin don amfanin jama'a.
Sakamakon ban mamaki da binciken ya bayyana
Wannan ba wai kawai wani bincike ba ne. Wannan gwaji ne da aka yi ta hanyar gwaji bazuwar, mai makanta biyu, kuma mai sarrafa placebo . Wato, an raba marasa lafiya zuwa ƙungiyoyi biyu, kuma an ba wa ƙungiya ɗaya ainihin maganin, ɗayan kuma an ba shi maganin jabu ba tare da wani sinadari mai aiki ba (placebo). Amma mara lafiya ko ƙungiyar da ke kula da marasa lafiya ba su san wanda ke shan maganin ba. Wannan hanyar tana ba mu damar auna ainihin ingancin maganin ba tare da nuna son kai ba.
Don haka bari mu duba wasu daga cikin sakamakon wannan bincike. Waɗannan sun nuna irin gagarumin bambanci da wannan zai iya yi a rayuwar masu fama da cutar Alzheimer.
| Babban ganowa | Bayanin sakamakon |
|---|---|
| Alamomin ba sa ƙara muni | Kashi 47% na waɗanda suka sha donanemab ba su nuna ƙaruwar alamun ba bayan shekara guda, idan aka kwatanta da kashi 29% kawai na waɗanda suka sha placebo. |
| Rage saurin kamuwa da cutar | Idan aka kwatanta da waɗanda suka sha maganin placebo, waɗanda suka sha Donanemab sun sami raguwar kashi 35% na yawan kamuwa da cutar. |
| Ikon yin ayyukan yau da kullun | Ikon yin ayyukan yau da kullun kamar su miya da yin shayi da kanka ya ragu da kashi 40% . Wannan babban sauƙi ne ga majiyyaci da kuma iyali. |
| Hadarin ci gaba zuwa mataki na gaba na cutar | Waɗanda suka sha Donanemab sun sami raguwar haɗarin ci gaba zuwa mataki na gaba, mafi tsanani na cutar da kashi 39% . |
| Matakan amyloid na kwakwalwa | Ko da cikin watanni 6 kacal da fara magani, matakan amyloid plaques a cikin kwakwalwar marasa lafiya sun ragu sosai. |
Binciken ya shafi marasa lafiya a farkon matakin cutar. An kuma rarraba su gwargwadon matakan tau , wani furotin da ke auna tsananin cutar. Abin mamaki, har ma da marasa lafiya da ke da cutar da tau mafi girma sun ga ɗan fa'ida daga maganin.
Muna kuma sane da illolin da ke tattare da hakan.
Kamar kowace magani, akwai wasu illoli da aka ruwaito. Yayin da muke magana game da bege, muna buƙatar mu kasance masu gaskiya game da waɗannan haɗarin.
Babban illar da ake gani da wannan maganin shine wata cuta da ake kira ARIA (Amyloid-Related Imaging Abnormalities) . A taƙaice dai, wannan kumburi ne na ɗan lokaci ko ƙaramin zubar jini a kwakwalwa. Ana kyautata zaton yana da alaƙa da tsarin cire amyloid.
- Kashi 24% na waɗanda suka sha DonanemabKumburin kwakwalwa ya faru, amma kashi 6% ne kawai na mutane suka nuna alamun cutar.
- Ƙaramin zubar jini ya faru a cikin kusan kashi 31% na marasa lafiya (wannan ma ya faru a cikin kashi 14% na waɗanda suka ɗauki placebo).
Mafi kyawun sashi shine yawancin waɗannan yanayin ARIA suna da sauƙi ko matsakaici kuma ana iya warkar da su ko daidaita su tare da maganin likita mai dacewa.
Duk da haka, bai kamata mu manta da wannan gaskiyar ba. Abin baƙin ciki, an kuma bayar da rahoton mutuwar mutane uku da suka shafi wannan yanayin ARIA a lokacin wannan binciken. Wannan yana nuna mana yadda kulawa ta likita take da matuƙar muhimmanci yayin amfani da irin wannan magani mai ƙarfi.
Me kwararru ke cewa game da wannan?
Masana ilimin jijiyoyi a duk faɗin duniya suna farin ciki da waɗannan sakamakon. Wasu suna cewa, "Yanzu mun shiga zamanin maganin cutar Alzheimer."
"Bayan shekaru da aka shafe ana gudanar da bincike ba tare da nasara ba, yanzu muna samun sakamako mai kyau wanda ke nuna cewa cire amyloid na iya canza yanayin cutar," in ji wani kwararre.
Wani muhimmin bangare na wannan maganin shine yadda ake ba shi. Bincike ya nuna cewa da zarar an rage sinadarin amyloid mai cutarwa a cikin kwakwalwa zuwa wani mataki, za a iya dakatar da maganin . An dakatar da magani ga kashi 52% na marasa lafiya cikin shekara guda da kuma kashi 72% cikin watanni 18. Wannan kamar "samun sassauci" daga cutar ne da kuma lura da ita ba tare da magani ba. Wannan na iya zama babban fa'ida ga marasa lafiya da kuma dangane da farashin magani.
Amma wasu ƙwararru har yanzu suna da ɗan taka tsantsan. Suna cewa, "Waɗannan sakamakon suna da kyau sosai, amma muna buƙatar ganin cikakken bayanai. Akwai manyan illoli, kuma muna buƙatar ƙarin sani game da yadda suke shafar marasa lafiya."
Saƙon Ɗauka Gida
- Donanemab ba magani bane ga cutar Alzheimer, amma magani ne da ke rage saurin ci gaban cutar, kuma yana ba da babban bege ga nan gaba.
- Wannan yana aiki ta hanyar cire allunan amyloid masu cutarwa waɗanda ke taruwa a cikin kwakwalwa.
- Wannan yana taimaka wa marasa lafiya, musamman a farkon matakin cutar, su ci gaba da tunawa da kuma iya yin ayyukan yau da kullun na tsawon lokaci.
- Kumburin kwakwalwa da ƙananan zubar jini (ARIA)Akwai haɗarin samun mummunan sakamako, don haka idan ka zaɓi yin wannan maganin, ya kamata a yi shi ƙarƙashin kulawar likita sosai.
- Wannan maganin har yanzu yana kan matakin bincike. Zai ɗauki ɗan lokaci kafin a samu damar amfani da shi a Sri Lanka. Saboda haka, idan wani a cikin iyalinka yana nuna alamun cutar Alzheimer, mafi kyawun abin da za a yi shi ne a ga likita mai ƙwarewa da wuri-wuri kuma a nemi shawara.
💬 Comments (0)
Har yanzu ba a buga sharhi ba. Ƙara bayanin ku anan a karon farko.
Ƙara sharhin ku